Jones Financial Companies
STOK icon

Jones Financial Companies’s Stoke Therapeutics STOK Stock Holding History

Jones Financial Companies’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.8K Hold
2,120
– – ﹤0.01% 2993
2026
Q1 		$69.6K Sell
2,120
-450
-18% -$14.8K ﹤0.01% 2822
2025
Q4 		$81.6K Sell
2,570
-730
-22% -$21.9K ﹤0.01% 2293
2025
Q3 		$79.7K Sell
3,300
-150
-4% -$2.57K ﹤0.01% 2171
2025
Q2 		$40.1K Buy
3,450
+500
+17% +$4.75K ﹤0.01% 2315
2025
Q1 		$21.3K Buy
2,950
+1,900
+181% +$17.7K ﹤0.01% 2410
2024
Q4 		$11.6K Buy
1,050
+1,000
+2,000% +$12.3K ﹤0.01% 2473
2024
Q3 		$612 Buy
+50
New +$708 ﹤0.01% 2869

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jones Financial Companies's STOK Position: Q2 2026 in Review

Jones Financial Companies held its Stoke Therapeutics (STOK) position steady in Q2 2026 at 2,120 shares worth $67.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2993.

Jones Financial Companies first reported a position in STOK in Q3 2024 and has held it in 8 quarters since. The position peaked at $81.6K in Q4 2025. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Jones Financial Companies held 2,120 shares of Stoke Therapeutics worth $67.8K as of Q2 2026.
  • Jones Financial Companies left its Stoke Therapeutics share count unchanged in Q2 2026.
  • Stoke Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2993 holding.
  • Jones Financial Companies first reported a position in Stoke Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Jones Financial Companies's Stoke Therapeutics position peaked at $81.6K in Q4 2025.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.